These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 28882182)
21. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma. Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550 [TBL] [Abstract][Full Text] [Related]
22. Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines. Hanke NT; Garland LL; Baker AF J Cancer Res Clin Oncol; 2016 Mar; 142(3):549-60. PubMed ID: 26385374 [TBL] [Abstract][Full Text] [Related]
23. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures. van der Waals LM; Laoukili J; Jongen JMJ; Raats DA; Borel Rinkes IHM; Kranenburg O Sci Rep; 2019 Jan; 9(1):819. PubMed ID: 30692572 [TBL] [Abstract][Full Text] [Related]
24. MTH1 expression is required for effective transformation by oncogenic HRAS. Giribaldi MG; Munoz A; Halvorsen K; Patel A; Rai P Oncotarget; 2015 May; 6(13):11519-29. PubMed ID: 25893378 [TBL] [Abstract][Full Text] [Related]
25. Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway. Kang KA; Piao MJ; Madduma Hewage SR; Ryu YS; Oh MC; Kwon TK; Chae S; Hyun JW Tumour Biol; 2016 Jul; 37(7):9615-24. PubMed ID: 26797785 [TBL] [Abstract][Full Text] [Related]
26. Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1. Zhang Q; Chen M; Cao L; Ren Y; Guo X; Wu X; Xu K Mol Carcinog; 2020 Jun; 59(6):590-603. PubMed ID: 32189414 [TBL] [Abstract][Full Text] [Related]
27. ω-Hydroxyundec-9-enoic acid induces apoptosis through ROS-mediated endoplasmic reticulum stress in non-small cell lung cancer cells. Yang KM; Kim BM; Park JB Biochem Biophys Res Commun; 2014 Jun; 448(3):267-73. PubMed ID: 24796672 [TBL] [Abstract][Full Text] [Related]
28. CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma. Wang Z; Yin F; Xu J; Zhang T; Wang G; Mao M; Wang Z; Sun W; Han J; Yang M; Jiang Y; Hua Y; Cai Z J Exp Clin Cancer Res; 2019 Jan; 38(1):44. PubMed ID: 30704503 [TBL] [Abstract][Full Text] [Related]
29. Clinical benefit of continuing crizotinib therapy after initial disease progression in Chinese patients with advanced ALK-rearranged non-small-cell lung cancer. Hong X; Chen Q; Ding L; Liang Y; Zhou N; Fang W; Chen X; Wu H Oncotarget; 2017 Jun; 8(25):41631-41640. PubMed ID: 28427213 [TBL] [Abstract][Full Text] [Related]
30. Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study. Cadranel J; Park K; Arrieta O; Pless M; Bendaly E; Patel D; Sasane M; Nosal A; Swallow E; Galebach P; Kageleiry A; Stein K; Degun R; Zhang J Lung Cancer; 2016 Aug; 98():9-14. PubMed ID: 27393500 [TBL] [Abstract][Full Text] [Related]
31. Curcumin exerts cytotoxicity dependent on reactive oxygen species accumulation in non-small-cell lung cancer cells. Wang C; Song X; Shang M; Zou W; Zhang M; Wei H; Shao H Future Oncol; 2019 Apr; 15(11):1243-1253. PubMed ID: 30843426 [TBL] [Abstract][Full Text] [Related]
32. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation. Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416 [TBL] [Abstract][Full Text] [Related]
34. Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer. van der Wekken AJ; Pelgrim R; 't Hart N; Werner N; Mastik MF; Hendriks L; van der Heijden EHFM; Looijen-Salamon M; de Langen AJ; Staal-van den Brekel J; Riemersma S; van den Borne BE; Speel EJM; Dingemans AC; Hiltermann TJN; van den Berg A; Timens W; Schuuring E; Groen HJM Clin Cancer Res; 2017 Aug; 23(15):4251-4258. PubMed ID: 28183714 [No Abstract] [Full Text] [Related]
35. Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells. Oh SJ; Noh KH; Lee YH; Hong SO; Song KH; Lee HJ; Kim S; Kim TM; Jeon JH; Seo JH; Kim DW; Kim TW Oncotarget; 2015 Nov; 6(37):40255-67. PubMed ID: 26517679 [TBL] [Abstract][Full Text] [Related]
36. Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations. Niu Y; Pan D; Shi D; Bai Q; Liu H; Yao X PLoS One; 2015; 10(12):e0145219. PubMed ID: 26677850 [TBL] [Abstract][Full Text] [Related]
37. Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer. Wu S; Zhao Q; Liu S; Kuang J; Zhang J; Onga A; Shen Y; Wang J; Sui H; Ni L; Ye Y; Tu X; Le HB; Zheng Y; Cui R; Zhu W Int J Oncol; 2024 Aug; 65(2):. PubMed ID: 38873997 [TBL] [Abstract][Full Text] [Related]
38. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140 [TBL] [Abstract][Full Text] [Related]
39. Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction. Xu Z; Shi Y; Zhu L; Luo J; Hu Q; Jiang S; Xiao M; Jiang X; Wang H; Xu Y; Jin W; Zhou Y; Wang P; Wang K Cancer Lett; 2024 Aug; 598():217075. PubMed ID: 38909775 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of crizotinib among Chinese EML4-ALK-positive, advanced-stage non-small cell lung cancer patients. Cao Y; Xiao G; Qiu X; Ye S; Lin T PLoS One; 2014; 9(12):e114008. PubMed ID: 25501361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]